Novel disinfectant formulation leveraging specialized extracellular hydroxyl radical (OH) production systems from plant pathogens, enhanced with inorganic and organic compounds for improved antimicrobial efficacy against bacteria and viruses.
This research proposes a novel disinfectant formulation that harnesses the specialized extracellular hydroxyl radical (OH) production systems naturally found in plant pathogens. These systems, which certain plant pathogens use to damage host plant surfaces and create infection sites, can be enhanced through the addition of specific inorganic and organic compounds. The resulting formulation aims to deliver potent antimicrobial action suitable for disinfection applications.
The value proposition centers on using biologically derived hydroxyl radical production systems as the active mechanism, offering an alternative approach to conventional disinfectant chemistries. By isolating and formulating factors from pathogens responsible for rapid plant infections such as rust, smuts, powdery mildew, and root rots, the approach seeks to create effective antimicrobial compositions.
Core technology:
Target microorganisms for validation:
Validation methodology:
The technology is at an early research stage. Preliminary indications suggest that certain factors can enhance the lethality of extracellular hydroxyl radicals produced by plant pathogens. The principal investigator brings relevant prior experience in plant pathology, having worked on disease-causing agents responsible for rusts, smuts, powdery mildew, and root rots from 1986 to 1995, and has identified and isolated factors associated with rapid crop infection. Proposed next steps include systematic formulation evaluation against representative bacterial and viral targets using a standardized glass slide assay methodology.
Bio-Detek, Incorporated is a medical device manufacturer based in Pawtucket, Rhode Island. The company specializes in the design and production of medical equipment and supplies, operating within the medical equipment manufacturing sector. Historically, the firm has been recognized as a manufacturer of specialized diagnostic and therapeutic medical components, including multi-function electrodes used in conjunction with defibrillators for medical professionals.
The company's operations have involved regulated medical product development, including filings for 510(k) premarket notification with the U.S. Food and Drug Administration. Its products have been distributed globally for clinical use, supporting critical applications such as defibrillation, cardioversion, and patient monitoring. In previous instances, the firm has managed regulatory compliance and device correction processes to ensure adherence to safety and sterility standards for its manufactured medical devices.